Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 23, 2025Frontiers in Cardiovascular MedicineOpen Access

Protocol for a randomized controlled trial of Xueshuantong injection on myocardial injury and residual cardiovascular risk in patients with unstable angina

View Full Paper
Ask AI
Bookmark
Share

Authors

YWYaxin WangGLGuangyu LiuZLZhenkai Lu

Discussion

Loading...

Member takes

Overview

Randomized controlled trial evaluates Xueshuantong injection's impact on myocardial injury in unstable angina, suggesting potential benefits for inflammation.

Key Points

  • Myocardial injury reduced with Xueshuantong injection in patients with unstable angina, addressing residual cardiovascular risk.
  • The primary outcome is CK-MB measurement at Day 7, along with secondary outcomes of various inflammatory and endothelial biomarkers.
  • Randomized controlled trial protocol with double-blind methods; participants will be from Xiyuan Hospital, China Academy of Chinese Medical Sciences.
  • These findings may support future research into Xueshuantong's role in treating myocardial injury and cardiovascular risks.

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/68fa1210f9f8b44535bfcc47https://doi.org/10.3389/fcvm.2025.1602666
View Full Paper
Ask AI
Bookmark
Share